SNTI
Senti Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.23
+0.84%Sep 24, 2026, 20:08 UTC
Brenda Cooperstone resigned as a member and Chair of the Compensation Committee of the Board of Senti Biosciences Holdings, Inc., effective September 23, 2026.
Sep 2, 2026, 20:36 UTC
Senti Biosciences Holdings, Inc. amended its Securities Purchase Agreement to authorize the issuance and sale of $2.0 million aggregate principal of Senior Secured Convertible Notes to NSG BioInnovation Fund, L.P. in a third tranche.
Aug 20, 2026, 00:00 UTC
Senti Biosciences Holdings, Inc. issued $4.0 million aggregate principal amount of Senior Secured Convertible Notes to Celadon Partners SPV 24 pursuant to an existing securities purchase agreement dated April 27, 2026.